Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Long-term Effect of Dupilumab on Acetylsalicylic Acid (ASA) Intolerance and Its Mechanisms in Patients With Non-steroidal Anti-inflammatory Drug-exacerbated Respiratory Disease (N-ERD)

NCT07049978 is registered in ClinicalTrials.gov with Medical University of Vienna as lead sponsor.

NCT NCT07049978
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07049978 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Long-term Effect of Dupilumab on Acetylsalicylic Acid (ASA) Intolerance and Its Mechanisms in Patients With Non-steroidal Anti-inflammatory Drug-exacerbated Respiratory Disease (N-ERD)
Lead sponsor
Medical University of Vienna
Phase
Observational
Overall status
Completed
Start date
September 1, 2025
Completion date
May 7, 2026
Enrollment
15 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

asthma bronchiale, chronic rhinosinusitis (crs), nasal polyposis, nsaid-induced asthma, nsaids hypersensitivity